Publication | Closed Access

The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation

TransplantationComposite AllograftHematologyImmunologyGraft SurvivalVascular BiologyVascularized Composite AllotransplantationWound HealingCell BiologyMitomycin-induced Blood CellsMedicineCell TransplantationTemporary TreatmentGraft Rejection